// App-Quantinova.ai

2843 : TASC1, a selective anti-senescence therapeutic which potently and selectively counteract resistance to chemo- and radiotherapy

Researchers

Presenter

  • Marjolein P. Baar

Principal Investigators

  • Diana A. Putavet

  • Joris Pothof

  • Jan H.J. Hoeijmakers

  • Peter L.J. de Keizer

Medical Centers

  • Erasmus MC, Rotterdam, Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved